Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carina Strell

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Cancer Research|January 23, 2013
Distinct effects of ligand-induced PDGFRα and PDGFRβ signaling in the human rhabdomyosarcoma tumor cell and stroma cell compartmentsMonika Ehnman, Edoardo Missiaglia, Erika Folestad, et al.
Neoplasia (New York, N.Y.)|November 19, 2021
Stabilization of the classical phenotype upon integration of pancreatic cancer cells into the duodenal epitheliumBenedek Bozóky, Carlos Fernández Moro, Carina Strell, et al.
Scientific Reports|December 28, 2020
Blocking PDGF-CC signaling ameliorates multiple sclerosis-like neuroinflammation by inhibiting disruption of the blood-brain barrierManuel Zeitelhofer, Milena Z Adzemovic, Christine Moessinger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2021
High PDGFRb Expression Predicts Resistance to Radiotherapy in DCIS within the SweDCIS Randomized TrialCarina Strell, Dick Folkvaljon, Erik Holmberg, et al.
European Journal of Cancer (Oxford, England : 1990)|March 3, 2022
Tumour-infiltrating lymphocytes add prognostic information for patients with low-risk DCIS: findings from the SweDCIS randomised radiotherapy trialAglaia Schiza, Viktoria Thurfjell, Axel Stenmark Tullberg, et al.
Scientific Reports|July 17, 2019
Differential prognostic impact of platelet-derived growth factor receptor expression in NSCLCThomas Karsten Kilvaer, Mehrdad Rakaee, Turid Hellevik, et al.
Ebiomedicine|April 25, 2026
Spatially resolved T cell receptor diversity mapping uncovers variability of the cancer immune microenvironmentAnastasia Magoulopoulou, Maria Chatzinikolaou, Andreas Metousis, et al.
Lung Cancer (Amsterdam, Netherlands)|March 11, 2021
Stromal FAP is an independent poor prognosis marker in non-small cell lung adenocarcinoma and associated with p53 mutationPablo Moreno-Ruiz, Sara Corvigno, Nienke C Te Grootenhuis, et al.
Glia|September 12, 2019
Astrocytes enhance glioblastoma growthAlessandro Mega, Mette Hartmark Nilsen, Lina Wik Leiss, et al.
Cell Communication and Signaling : CCS|January 16, 2026
In situ mapping of activated PDGFRβ defines a prognostic discrepancy between histological subtypes of NSCLCAmanda Lindberg, Louise Hellberg, Anaïs Grandon, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Cancer Research|January 23, 2013
Distinct effects of ligand-induced PDGFRα and PDGFRβ signaling in the human rhabdomyosarcoma tumor cell and stroma cell compartmentsMonika Ehnman, Edoardo Missiaglia, Erika Folestad, et al.
Neoplasia (New York, N.Y.)|November 19, 2021
Stabilization of the classical phenotype upon integration of pancreatic cancer cells into the duodenal epitheliumBenedek Bozóky, Carlos Fernández Moro, Carina Strell, et al.
Scientific Reports|December 28, 2020
Blocking PDGF-CC signaling ameliorates multiple sclerosis-like neuroinflammation by inhibiting disruption of the blood-brain barrierManuel Zeitelhofer, Milena Z Adzemovic, Christine Moessinger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2021
High PDGFRb Expression Predicts Resistance to Radiotherapy in DCIS within the SweDCIS Randomized TrialCarina Strell, Dick Folkvaljon, Erik Holmberg, et al.
European Journal of Cancer (Oxford, England : 1990)|March 3, 2022
Tumour-infiltrating lymphocytes add prognostic information for patients with low-risk DCIS: findings from the SweDCIS randomised radiotherapy trialAglaia Schiza, Viktoria Thurfjell, Axel Stenmark Tullberg, et al.
Scientific Reports|July 17, 2019
Differential prognostic impact of platelet-derived growth factor receptor expression in NSCLCThomas Karsten Kilvaer, Mehrdad Rakaee, Turid Hellevik, et al.
Ebiomedicine|April 25, 2026
Spatially resolved T cell receptor diversity mapping uncovers variability of the cancer immune microenvironmentAnastasia Magoulopoulou, Maria Chatzinikolaou, Andreas Metousis, et al.
Lung Cancer (Amsterdam, Netherlands)|March 11, 2021
Stromal FAP is an independent poor prognosis marker in non-small cell lung adenocarcinoma and associated with p53 mutationPablo Moreno-Ruiz, Sara Corvigno, Nienke C Te Grootenhuis, et al.
Glia|September 12, 2019
Astrocytes enhance glioblastoma growthAlessandro Mega, Mette Hartmark Nilsen, Lina Wik Leiss, et al.
Cell Communication and Signaling : CCS|January 16, 2026
In situ mapping of activated PDGFRβ defines a prognostic discrepancy between histological subtypes of NSCLCAmanda Lindberg, Louise Hellberg, Anaïs Grandon, et al.
Pageof 7